CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 70 filers reported holding CASI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $131,000 | -18.1% | 54,400 | 0.0% | 0.00% | – |
| Q4 2020 | $160,000 | +86.0% | 54,400 | -3.4% | 0.00% | – |
| Q3 2020 | $86,000 | -52.5% | 56,300 | -22.0% | 0.00% | – |
| Q2 2020 | $181,000 | +50.8% | 72,200 | +22.4% | 0.00% | – |
| Q1 2020 | $120,000 | -20.5% | 59,000 | +20.9% | 0.00% | – |
| Q4 2019 | $151,000 | -7.4% | 48,800 | 0.0% | 0.00% | – |
| Q3 2019 | $163,000 | +10.9% | 48,800 | +6.1% | 0.00% | – |
| Q2 2019 | $147,000 | +32.4% | 46,000 | +19.2% | 0.00% | – |
| Q1 2019 | $111,000 | +18.1% | 38,600 | +65.0% | 0.00% | – |
| Q4 2018 | $94,000 | +34.3% | 23,400 | +57.0% | 0.00% | – |
| Q3 2018 | $70,000 | -29.3% | 14,900 | +24.2% | 0.00% | – |
| Q2 2018 | $99,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,934,000 | 16.36% |
| Wellington Shields & Co., LLC | 1,585,609 | $3,964,000 | 1.74% |
| Wellington Shields Capital Management, LLC | 1,321,745 | $3,304,000 | 0.53% |
| Ikarian Capital, LLC | 1,039,910 | $2,600,000 | 0.21% |
| Zebra Capital Management LLC | 50,658 | $127,000 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,183 | $348,000 | 0.02% |
| Manatuck Hill Partners, LLC | 15,090 | $38,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,200 | $513,000 | 0.01% |
| IHT Wealth Management, LLC | 26,000 | $65,000 | 0.01% |
| Vident Investment Advisory, LLC | 67,540 | $169,000 | 0.01% |